{"id":122668,"date":"2025-06-10T00:09:56","date_gmt":"2025-06-09T17:09:56","guid":{"rendered":"https:\/\/hmm88i.com\/drug\/?post_type=product&p=122668"},"modified":"2025-07-24T13:13:04","modified_gmt":"2025-07-24T06:13:04","slug":"trelegy-ellipta","status":"publish","type":"product","link":"https:\/\/hmm88i.com\/drug\/trelegy-ellipta\/","title":{"rendered":"Trelegy Ellipta"},"content":{"rendered":"

Trong b\u00e0i vi\u1ebft n\u00e0y, d\u01b0\u1ee3c s\u0129 L\u01b0u V\u0103n Ho\u00e0ng gi\u1edbi thi\u1ec7u \u0111\u1ebfn c\u00e1c b\u1ea1n thu\u1ed1c Trelegy Ellipta \u0111\u01b0\u1ee3c s\u1ea3n xu\u1ea5t b\u1edfi Glaxo Operations UK Ltd (trading as Glaxo Wellcome Operations) c\u00f3 s\u1ed1 \u0111\u0103ng k\u00fd l\u01b0u h\u00e0nh t\u1ea1i Vi\u1ec7t Nam l\u00e0 500110439823<\/strong><\/p>\n

Trelegy Ellipta l\u00e0 thu\u1ed1c g\u00ec?<\/h2>\n

Th\u00e0nh ph\u1ea7n<\/h3>\n

Trong m\u1ed7i li\u1ec1u h\u00edt Trelegy Ellipta<\/strong> c\u00f3 ch\u1ee9a:<\/p>\n

    \n
  • Fluticasone furoate 100mcg<\/li>\n
  • Umeclidinium 62,5mcg (t\u01b0\u01a1ng \u0111\u01b0\u01a1ng v\u1edbi 74,2mcg umeclidinium bromide)<\/li>\n
  • Vilanterol (d\u1ea1ng trifenatate) 25mcg<\/li>\n<\/ul>\n

    D\u1ea1ng b\u00e0o ch\u1ebf: Thu\u1ed1c b\u1ed9t h\u00edt ph\u00e2n li\u1ec1u<\/p>\n

    Tr\u00ecnh b\u00e0y<\/h3>\n

    S\u0110K: 500110439823<\/p>\n

    Quy c\u00e1ch \u0111\u00f3ng g\u00f3i: H\u1ed9p c\u00f3 1 d\u1ee5ng c\u1ee5 h\u00edt ch\u1ee9a 30 li\u1ec1u h\u00edt<\/p>\n

    Xu\u1ea5t x\u1ee9: V\u01b0\u01a1ng qu\u1ed1c Anh<\/p>\n

    H\u1ea1n s\u1eed d\u1ee5ng: 24 th\u00e1ng<\/p>\n

    T\u00e1c d\u1ee5ng c\u1ee7a thu\u1ed1c Trelegy Ellipta<\/h2>\n

    C\u01a1 ch\u1ebf t\u00e1c d\u1ee5ng<\/h3>\n
      \n
    • Trelegy Ellipta l\u00e0 s\u1ef1 k\u1ebft h\u1ee3p c\u1ee7a ba ho\u1ea1t ch\u1ea5t thu\u1ed9c c\u00e1c nh\u00f3m d\u01b0\u1ee3c l\u00fd kh\u00e1c nhau: corticosteroid t\u1ed5ng h\u1ee3p, ch\u1ea5t kh\u00e1ng muscarinic t\u00e1c d\u1ee5ng k\u00e9o d\u00e0i (LAMA), v\u00e0 thu\u1ed1c ch\u1ee7 v\u1eadn beta-2 ch\u1ecdn l\u1ecdc t\u00e1c d\u1ee5ng k\u00e9o d\u00e0i (LABA).<\/li>\n
    • Fluticasone furoate l\u00e0 corticosteroid m\u1ea1nh, c\u00f3 t\u00e1c d\u1ee5ng ch\u1ed1ng vi\u00eam b\u1eb1ng c\u00e1ch \u1ee9c ch\u1ebf ho\u1ea1t \u0111\u1ed9ng c\u1ee7a c\u00e1c t\u1ebf b\u00e0o v\u00e0 ph\u00e2n t\u1eed trung gian trong ph\u1ea3n \u1ee9ng vi\u00eam \u0111\u01b0\u1eddng h\u00f4 h\u1ea5p.<\/li>\n
    • Umeclidinium ho\u1ea1t \u0111\u1ed9ng b\u1eb1ng c\u00e1ch ng\u0103n ch\u1eb7n th\u1ee5 th\u1ec3 muscarinic tr\u00ean c\u01a1 tr\u01a1n ph\u1ebf qu\u1ea3n, l\u00e0m gi\u1ea3m co th\u1eaft ph\u1ebf qu\u1ea3n v\u00e0 gi\u00fap gi\u00e3n ph\u1ebf qu\u1ea3n hi\u1ec7u qu\u1ea3 trong th\u1eddi gian d\u00e0i.<\/li>\n
    • Vilanterol k\u00edch th\u00edch th\u1ee5 th\u1ec3 beta-2 adrenergic, l\u00e0m t\u0103ng s\u1ea3n xu\u1ea5t AMP v\u00f2ng, t\u1eeb \u0111\u00f3 th\u01b0 gi\u00e3n c\u01a1 tr\u01a1n \u0111\u01b0\u1eddng d\u1eabn kh\u00ed v\u00e0 gi\u1ea3m gi\u1ea3i ph\u00f3ng c\u00e1c ch\u1ea5t g\u00e2y ph\u1ea3n \u1ee9ng vi\u00eam t\u1ee9c th\u00ec.<\/li>\n<\/ul>\n

      \u0110\u1eb7c \u0111i\u1ec3m d\u01b0\u1ee3c \u0111\u1ed9ng h\u1ecdc<\/h3>\n

      Fluticasone furoate: Sau khi h\u00edt, thu\u1ed1c \u0111\u1ea1t n\u1ed3ng \u0111\u1ed9 \u0111\u1ec9nh trong huy\u1ebft t\u01b0\u01a1ng kho\u1ea3ng 15 ph\u00fat. Sinh kh\u1ea3 d\u1ee5ng to\u00e0n th\u00e2n trung b\u00ecnh kho\u1ea3ng 15%, ch\u1ee7 y\u1ebfu \u0111\u01b0\u1ee3c h\u1ea5p thu t\u1ea1i ph\u1ed5i, r\u1ea5t \u00edt h\u1ea5p thu qua \u0111\u01b0\u1eddng ti\u00eau h\u00f3a. Sau nhi\u1ec1u ng\u00e0y s\u1eed d\u1ee5ng, tr\u1ea1ng th\u00e1i \u1ed5n \u0111\u1ecbnh \u0111\u1ea1t \u0111\u01b0\u1ee3c trong v\u00f2ng 6 ng\u00e0y v\u1edbi s\u1ef1 t\u00edch t\u1ee5 nh\u1eb9. Thu\u1ed1c li\u00ean k\u1ebft m\u1ea1nh v\u1edbi protein huy\u1ebft t\u01b0\u01a1ng (>99,6%) v\u00e0 \u0111\u01b0\u1ee3c chuy\u1ec3n h\u00f3a ch\u1ee7 y\u1ebfu qua enzym CYP3A4, th\u1ea3i tr\u1eeb ch\u1ee7 y\u1ebfu qua ph\u00e2n.<\/p>\n

      Umeclidinium: Thu\u1ed1c nhanh ch\u00f3ng \u0111\u1ea1t n\u1ed3ng \u0111\u1ed9 \u0111\u1ec9nh trong kho\u1ea3ng 5 ph\u00fat sau khi h\u00edt. Sinh kh\u1ea3 d\u1ee5ng to\u00e0n th\u00e2n trung b\u00ecnh kho\u1ea3ng 13%, h\u1ea5p thu qua \u0111\u01b0\u1eddng ti\u00eau h\u00f3a r\u1ea5t th\u1ea5p. Thu\u1ed1c g\u1eafn k\u1ebft kho\u1ea3ng 89% v\u1edbi protein huy\u1ebft t\u01b0\u01a1ng, \u0111\u01b0\u1ee3c chuy\u1ec3n h\u00f3a ch\u00ednh b\u1edfi CYP2D6 v\u00e0 th\u1ea3i tr\u1eeb qua ph\u00e2n v\u00e0 n\u01b0\u1edbc ti\u1ec3u. Th\u1eddi gian b\u00e1n th\u1ea3i huy\u1ebft t\u01b0\u01a1ng kho\u1ea3ng 19 gi\u1edd.<\/p>\n

      Vilanterol: N\u1ed3ng \u0111\u1ed9 \u0111\u1ec9nh \u0111\u1ea1t trong huy\u1ebft t\u01b0\u01a1ng sau kho\u1ea3ng 7 ph\u00fat h\u00edt thu\u1ed1c, sinh kh\u1ea3 d\u1ee5ng trung b\u00ecnh 27%. Thu\u1ed1c li\u00ean k\u1ebft kho\u1ea3ng 94% v\u1edbi protein huy\u1ebft t\u01b0\u01a1ng v\u00e0 \u0111\u01b0\u1ee3c chuy\u1ec3n h\u00f3a ch\u1ee7 y\u1ebfu qua CYP3A4. Th\u1eddi gian b\u00e1n th\u1ea3i c\u1ee7a Vilanterol l\u00e0 kho\u1ea3ng 11 gi\u1edd, ch\u1ee7 y\u1ebfu th\u1ea3i tr\u1eeb qua n\u01b0\u1edbc ti\u1ec3u v\u00e0 ph\u00e2n d\u01b0\u1edbi d\u1ea1ng c\u00e1c ch\u1ea5t chuy\u1ec3n h\u00f3a.<\/p>\n

      Thu\u1ed1c Trelegy Ellipta \u0111\u01b0\u1ee3c ch\u1ec9 \u0111\u1ecbnh trong b\u1ec7nh g\u00ec?<\/h2>\n

      Thu\u1ed1c h\u00edt \u0111\u1ecbnh li\u1ec1u Trelegy Ellipta<\/strong> \u0111\u01b0\u1ee3c ch\u1ec9 \u0111\u1ecbnh \u0111\u1ec3 \u0111i\u1ec1u tr\u1ecb duy tr\u00ec b\u1ec7nh ph\u1ed5i t\u1eafc ngh\u1ebdn m\u1ea1n t\u00ednh (COPD), nh\u1eb1m ph\u00f2ng ng\u1eeba v\u00e0 gi\u1ea3m nh\u1eb9 tri\u1ec7u ch\u1ee9ng.<\/p>\n

      \"Trelegy
      Thu\u1ed1c Trelegy Ellipta l\u00e0 s\u1ef1 thu\u1ed1c ph\u1ed1i h\u1ee3p ba ho\u1ea1t ch\u1ea5t gi\u00fap h\u1ed7 tr\u1ee3 \u0111i\u1ec1u tr\u1ecb b\u1ec7nh ph\u1ed5i t\u1eafc ngh\u1ebdn m\u1ea1n t\u00ednh (COPD) v\u1edbi c\u01a1 ch\u1ebf t\u00e1c d\u1ee5ng \u0111a di\u1ec7n v\u00e0 hi\u1ec7u qu\u1ea3 k\u00e9o d\u00e0i.<\/figcaption><\/figure>\n

      Li\u1ec1u d\u00f9ng v\u00e0 c\u00e1ch s\u1eed d\u1ee5ng<\/h2>\n

      Li\u1ec1u d\u00f9ng<\/h3>\n